Paliperidone NDC 72658-1256

NDC codes

FDA NDC Directory

Product NDC (as listed)72658-1256Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72658-1256Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
72658-1256-1	72658125601	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1256-1)Marketed from Oct 2, 2025
72658-1256-2	72658125602	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1256-2)Marketed from Oct 2, 2025
72658-1256-3	72658125603	500 TABLET, EXTENDED RELEASE in 1 PACKAGE (72658-1256-3)Marketed from Oct 2, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Paliperidone
Generic name (nonproprietary): paliperidone
Active ingredients: Paliperidone — 9 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Eskayef Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218755
Marketing start: Oct 2, 2025
Listing expires: Dec 31, 2026
Identifiers: Product ID 72658-1256_3e4a14d9-8d90-5f05-e063-6294a90a110eSPL ID 3e4a14d9-8d90-5f05-e063-6294a90a110eSPL set ID de95e29f-a030-4777-a601-874500ab8e91RxCUI 672567, 672569, 672571, 866103UNII 838F01T721
Pharmacologic class: Atypical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472658125601 followed by a unit qualifier and the quantity

Package 72658-1256-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 8, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Paliperidone Extended-Release Tablets are an atypical antipsychotic agent indicated for Treatment of schizophrenia ( 1.1 ) Adults: Efficacy was established in three 6-week trials and one maintenance trial. ( 14.1 ) Adolescents (ages 12–17): Efficacy was established in one 6-week trial. ( 14.1 ) Treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and/or antidepressants. ( 1.2 ) Efficacy was established in two 6-week trials in adult patients. ( 14.2 ) 1.1 Schizophrenia Paliperidone Extended-Release Tablets are indicated for the treatment of schizophrenia [See Clinical Studies (14.1) ] . The efficacy of Paliperidone Extended-Release Tablets in schizophreni…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 218755

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218755
Product	Strength	Form · route	Labeler	Product NDC
Paliperidone	Paliperidone 6 mg/1	Tablet, Extended releaseOral	Westminster Pharmaceuticals, LLC	69367-434
Paliperidone	Paliperidone 1.5 mg/1	Tablet, Extended releaseOral	Westminster Pharmaceuticals, LLC	69367-432
Paliperidone	Paliperidone 3 mg/1	Tablet, Extended releaseOral	Westminster Pharmaceuticals, LLC	69367-433
Paliperidone	Paliperidone 9 mg/1	Tablet, Extended releaseOral	Westminster Pharmaceuticals, LLC	69367-435
Paliperidone	Paliperidone 6 mg/1	Tablet, Extended releaseOral	Eskayef Pharmaceuticals Limited	72658-1255
Paliperidone	Paliperidone 1.5 mg/1	Tablet, Extended releaseOral	Eskayef Pharmaceuticals Limited	72658-1253
Paliperidone	Paliperidone 3 mg/1	Tablet, Extended releaseOral	Eskayef Pharmaceuticals Limited	72658-1254
Paliperidone	Paliperidone 3 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	72162-2649
Paliperidone	Paliperidone 1.5 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	72162-2648
Paliperidone	Paliperidone 6 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	72162-2650
Paliperidone	Paliperidone 9 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	72162-2651